Skip to main content

Advertisement

SpringerLink
Log in

Characteristics and outcomes of patients with solid tumors receiving chemotherapy in the intensive care unit

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

The objective of this study was to evaluate the short- and long-term outcomes of adult patients with solid tumors receiving chemotherapy in the intensive care unit (ICU).

Methods

This was a retrospective single-center study comparing the outcomes of patients with solid tumors who received chemotherapy in the ICU with a matched cohort of ICU patients (by age, sex, and tumor type) who did not receive chemotherapy. Conditional logistic regression and shared frailty Cox regression were used to assess short-term (ICU and hospital) mortality and death by 12-month post-hospital discharge, respectively.

Results

Seventy-three patients with solid tumors who received chemotherapy in the ICU were successfully matched. The most common solid tumors included thoracic (30%), genitourinary (26%), and breast (16%). The ICU, hospital, and 12-month (post discharge)  mortality rates of patients who recieved chomtherapy in the ICU were 23%, 36%, and 43%, respectively. When compared to the matched cohort of patients who did not receive chemotherapy, patients who received chemotherapy had a significantly longer length of stay in the ICU (median 7 vs. 4 days, p < 0.001) and hospital (median 15 vs. 11 days, p = 0.011) but similar short-term ICU and hospital mortality rates (23% vs. 18% and 36% vs. 38%, respectively). Patients who received chemotherapy in the ICU were at a lower risk of death by 12 months (HR 0.31, p < 0.001) compared to the matched cohort on multivariable analysis.

Conclusions

Patients with solid tumors who received chemotherapy had increased ICU and hospital length of stay compared to patients who did not. Although short-term mortality did not differ, patients who received chemotherapy in the ICU had improved long-term survival. Our data can inform critical care triage decisions to include patients who are to receive chemotherapy in the ICU.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

Supplemental digital content is available for this article.

References

  1. Puxty K, McLoone P, Quasim T (2015) Risk of critical illness among patients with solid cancers: a population-based observational study. JAMA Oncol 1(8):1078–1085

    Article  Google Scholar 

  2. Shimabukuro-Vornhagen A, Boll B, Kochanek M, Azoulay E, von Bergwelt-Baildon MS (2016) Critical care of patients with cancer. CA Cancer J Clin 66:496–517

    Article  Google Scholar 

  3. Wigmore T, Farquhar-Smith P (2016) Outcomes for critically ill cancer patients in the ICU: current trends and prediction. Int Anesthesiol Clin 54(4):e62–e75

    Article  Google Scholar 

  4. Bos MM, Verburg IW, Dumaij I, Stouthard J, Nortier JW, Richel D, van der Zwan E, de Keizer NF, de Jonge E (2015) Intensive care admission of cancer patients: a comparative analysis. Cancer Med 4(7):966–976

    Article  Google Scholar 

  5. Torres VB, Vassalo J, Silva UV, Caruso P, Torelly AP, Silva E, Teles JM, Knibel M, Rezende E, Netto JJ, Piras C, Azevedo LC, Bozza FA, Spector N, Salluh JI, Soares M (2016) Outcomes in critically ill patients with cancer-related complications. PLoS One 11(10):e0164537

    Article  Google Scholar 

  6. Mokart D, Pastores SM, Darmon M (2014) Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med 40(10):1570–1572

    Article  Google Scholar 

  7. Zerbib Y, Rabbat A, Fartoukh M, et al; Groupe de Recherche sur la Réanimation Respiratoire en Onco-Hématologie (GRRR-OH). Urgent chemotherapy for life-threatening complications related to solid neoplasms. Crit Care Med 2017;45(7):e640-e648

  8. de Oliveira MCF, Ferreira JC, Nassar Junior AP, Dettino ALA, Caruso P (2017) Impact of urgent chemotherapy in critically ill patients. J Intensive Care Med 885066617748602

  9. Chen YF, Lin JW, Ho CC, Yang CY, Chang CH, Huang TM, Chen CY, Chen KY, Shih JY, Yu CJ (2017) Outcomes of cancer therapy administered to treatment-naïve lung cancer patients in the intensive care unit. J Cancer 8(11):1995–2003

    Article  Google Scholar 

  10. Hsia TC, Tu CY, Chen HJ (2014) The impact of rescue or maintenance therapy with EGFR TKIs for stage IIIb-IV non-squamous non-small-cell lung cancer patients requiring mechanical ventilation. BMC Anesthesiol 14:55

    Article  Google Scholar 

  11. Darmon M, Thiery G, Ciroldi M, de Miranda S, Galicier L, Raffoux E, le Gall JR, Schlemmer B, Azoulay E (2005) Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med 33(11):2488–2493

    Article  Google Scholar 

  12. Song JU, Suh GY, Chung MP, Kim H, Kwon OJ, Jung CW, Kang WK, Park K, Jeon K (2011) Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit. Support Care Cancer 19(4):491–495

    Article  Google Scholar 

  13. Wohlfarth P, Staudinger T, Sperr WR, Bojic A, Robak O, Hermann A, Laczika K, Carlström A, Riss K, Rabitsch W, Bojic M, Knoebl P, Locker GJ, Obiditsch M, Fuhrmann V, Schellongowski P, Arbeitsgruppe für hämato-onkologische Intensivmedizin der Österreichischen Gesellschaft für Internistische und Allgemeine Intensivmedizin und Notfallmedizin (ÖGIAIN) (2014) Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit. Ann Hematol 93(10):1629–1636

    Article  CAS  Google Scholar 

  14. Charlson ME, Pompei P, Ales KL, MacKenzie C (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

    Article  CAS  Google Scholar 

  15. Schoenfeld D (2006) Survival methods, including those using competing risks analysis, are not appropriate for intensive care unit outcome studies. Crit Care 10(1):103

    Article  Google Scholar 

  16. Pastores SM, Goldman DA, Shaz DJ, Kostelecky N, Daley RJ, Peterson TJ, Tan KS, Halpern NA (2018) Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit. Cancer 124(14):3025–3036

    Article  Google Scholar 

  17. Bergwelt-Baildon M, Hallek MJ, Shimabukuro-Vornhagen AA, Kochanek M (2010) CCC meets ICU: redefining the role of critical care of cancer patients. BMC Cancer 10:612

    Article  Google Scholar 

Download references

Acknowledgments

We acknowledge the assistance of Gleb Kirnicinii, Senior Application Analyst, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY for data management and pre-analysis.

Funding

This study was supported, in part, by the Core Grant (P30 CA008748) and the Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

Author information

Author notes

  1. David J Shaz, Stephen M Pastores and Neil A Halpern contributed equally to this work.

Authors and Affiliations

  1. Critical Care Center, Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue C-1179, New York, NY, 10065, USA

    David J Shaz, Stephen M Pastores, Natalie Kostelecky & Neil A Halpern

  2. Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Debra A Goldman & Kay See Tan

  3. Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Richard F Tizon

Authors
  1. David J Shaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen M Pastores
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Debra A Goldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Natalie Kostelecky
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Richard F Tizon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kay See Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Neil A Halpern
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conception and design: Stephen M Pastores, David Shaz, Neil A Halpern.

Provision of study materials or patients: Stephen M Pastores, David Shaz, Neil A Halpern.

Collection and assembly of data: All authors.

Data analysis and interpretation: All authors.

Manuscript writing: All authors.

Final approval of manuscript: All authors.

Corresponding author

Correspondence to David J Shaz.

Ethics declarations

Disclaimer

The authors have full control of all primary data and agree to allow the journal to review their data if requested. All authors had full access to all the data (including statistical reports and tables) in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 50 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shaz, D.J., Pastores, S.M., Goldman, D.A. et al. Characteristics and outcomes of patients with solid tumors receiving chemotherapy in the intensive care unit. Support Care Cancer 28, 3855–3865 (2020). https://doi.org/10.1007/s00520-019-05226-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-019-05226-w

Keywords

Search

Navigation